Abstract
Metabolomics is the systematic study of metabolite profiles of complex biological systems, and involves the systematic identification and quantification of metabolites. Metabolism is integrated with all biochemical reactions in biological systems; thus metabolite profiles provide collective information on biochemical processes induced by genetic or environmental perturbations. Transcriptomes or proteomes may not be functionally active and not always reflect phenotypic variations. The metabolome, however, consists of the biomolecules closest to the phenotype of living organisms, and is often called the molecular phenotype of biological systems. Thus, metabolome alterations can easily result in disease states, providing important clues to understand pathophysiological mechanisms contributing to various biomedical symptoms. The metabolome and metabolomics have been emphasized in translational research related to biomarker discovery, drug target discovery, drug responses, and disease mechanisms. This review describes the basic concepts, workflows, and applications of mass spectrometry-based metabolomics in translational research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Amal AL, Funka K, Skapars R, Sivins A, Ancans G, Liepniece-Karele I, Kikuste I, Lasina I, Haick H (2015) Detection of precancerous gastric lesions and gastric cancer through exhaled breath. Gut 65:1–8
Anand S, Young S, Esplin MS, Peaden B, Tolley HD, Porter TF et al (2016) Detection and confirmation of serum lipid biomarkers for preeclampsia using direct infusion mass spectrometry. J Lipid Res 57(4):687–696
Antolin EM, Delange DM, Canavaciolo VG (2008) Evaluation of five methods for derivatization and GC determination of a mixture of very long chain fatty acids (C24:0-C36:0). J Pharm Biomed Anal 46(1):194–199
Aubin MC, Lajoie C, Clement R, Gosselin H, Calderone A, Perrault LP (2008) Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol. J Pharmacol Exp Ther 325(3):961–968
Bergholt MS, Serio A, McKenzie JS, Boyd A, Soares RF, Tillner J et al (2018) Correlated Heterospectral Lipidomics for biomolecular profiling of Remyelination in multiple sclerosis. ACS Cent Sci 4(1):39–51
Bhargava P, Fitzgerald KC, Calabresi PA, Mowry EM (2017) Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation. JCI Insight 2(19):e95302
Birbrair A, Zhang T, Files DC, Mannava S, Smith T, Wang ZM et al (2014) Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Res Ther 5(6):122
Bogdanov B, Smith RD (2005) Proteomics by FTICR mass spectrometry: top down and bottom up. Mass Spectrom Rev 24(2):168–200
Bondia-Pons I, Nordlund E, Mattila I, Katina K, Aura AM, Kolehmainen M et al (2011) Postprandial differences in the plasma metabolome of healthy Finnish subjects after intake of a sourdough fermented endosperm rye bread versus white wheat bread. Nutr J 10:116
Boskey AL, Mendelsohn R (2005) Infrared spectroscopic characterization of mineralized tissues. Vib Spectrosc 38(1-2):107–114
Boudah S, Olivier MF, Aros-Calt S, Oliveira L, Fenaille F, Tabet JC et al (2014) Annotation of the human serum metabolome by coupling three liquid chromatography methods to high-resolution mass spectrometry. J Chromatogr 966:34–47
Bowen BP, Northen TR (2010) Dealing with the unknown: metabolomics and metabolite atlases. J Am Soc Mass Spectrom 21(9):1471–1476
Broadhurst D, Goodacre R, Reinke SN, Kuligowski J, Wilson ID, Lewis MR et al (2018) Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics 14(6):72
Broza YY, Kremer R, Tisch U, Gevorkyan A, Shiban A, Best LA et al (2013) A nanomaterial-based breath test for short-term follow-up after lung tumor resection. Nanomedicine 9(1):15–21
Capuano R, Santonico M, Pennazza G, Ghezzi S, Martinelli E, Roscioni C et al (2015) The lung cancer breath signature: a comparative analysis of exhaled breath and air sampled from inside the lungs. Sci Rep 5:16491
Cazzola MS, Capuano R, Bergamini A, Martinelli E, Calzetta L, Rogliani P, Ciaprini C, Ora J, Paolesse R, Di Natale C, D’Amico A (2015) Analysis of exhaled breath fingerprints and volatile organic compounds in COPD. COPD Research and Practice 10:1
Ceglarek U, Leichtle A, Brugel M, Kortz L, Brauer R, Bresler K et al (2009) Challenges and developments in tandem mass spectrometry based clinical metabolomics. Mol Cell Endocrinol 301(1–2):266–271
Cha JH, Bae SH, Kim HL, Park NR, Choi ES, Jung ES et al (2013) Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis. PLoS One 8(11):e77899
Chan JC, Kioh DY, Yap GC, Lee BW, Chan EC (2017) A novel LCMSMS method for quantitative measurement of short-chain fatty acids in human stool derivatized with (12)C- and (13)C-labelled aniline. J Pharm Biomed Anal 138:43–53
Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G et al (2018) MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 46(W1):W486–WW94
Claude E, Jones EA, Pringle SD (2017) DESI mass spectrometry imaging (MSI). Methods Mol Biol 1618:65–75
Cooper SD, Kyriazakis I, Nolan JV (1995) Diet selection in sheep: the role of the rumen environment in the selection of a diet from two feeds that differ in their energy density. Br J Nutr 74(1):39–54
Crow YJ, Wakeland EK (2012) Autoimmunity. Curr Opin Immunol 24(6):649–650
Das S, Pal S, Mitra M (2016) Significance of exhaled breath test in clinical diagnosis: a special focus on the detection of diabetes mellitus. J Med Biol Eng 36(5):605–624
Defernez M, Colquhoun IJ (2003) Factors affecting the robustness of metabolite fingerprinting using 1H NMR spectra. Phytochemistry 62(6):1009–1017
Deleris G, Petibois C (2003) Applications of FT-IR spectrometry to plasma contents. Vib Spectrosc 32:129–136
Dennis EA, Norris PC (2015) Eicosanoid storm in infection and inflammation. Nat Rev Immunol 15(8):511–523
Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N et al (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 6(7):1060–1083
Emwas A-HM (2015) The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. Methods Mol Biol 1227:161–193
Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E (2009) Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 81(16):6656–6667
Fendt SM, Buescher JM, Rudroff F, Picotti P, Zamboni N, Sauer U (2010) Tradeoff between enzyme and metabolite efficiency maintains metabolic homeostasis upon perturbations in enzyme capacity. Mol Syst Biol 6:356
Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM (1989) Electrospray ionization for mass spectrometry of large biomolecules. Science 246(4926):64–71
Fessenden M (2016) Metabolomics: small molecules, single cells. Nature 540(7631):153–155
Fiehn O (2016) Metabolomics by gas chromatography-mass spectrometry: combined targeted and untargeted profiling. Curr Protoc Mol Biol 114:30–42
Forsberg EM, Huan T, Rinehart D, Benton HP, Warth B, Hilmers B et al (2018) Data processing, multi-omic pathway mapping, and metabolite activity analysis using XCMS online. Nat Protoc 13(4):633–651
Fushimi T, Suruga K, Oshima Y, Fukiharu M, Tsukamoto Y, Goda T (2006) Dietary acetic acid reduces serum cholesterol and triacylglycerols in rats fed a cholesterol-rich diet. Br J Nutr 95(5):916–924
Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M et al (2009a) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58(7):1509–1517
Gao X, Pujos-Guillot E, Martin JF, Galan P, Juste C, Jia W et al (2009b) Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem 393(2):163–175
Garcia A, Barbas C (2011) Gas chromatography-mass spectrometry (GC-MS)-based metabolomics. Methods Mol Biol 708:191–204
Gathungu RM, Bird SS, Sheldon DP, Kautz R, Vouros P, Matson WR et al (2014) Identification of metabolites from liquid chromatography-coulometric array detection profiling: gas chromatography-mass spectrometry and refractionation provide essential information orthogonal to LC-MS/microNMR. Anal Biochem 454:23–32
Gieger C, Geistlinger L, Altmaier E, Hrabe de Angelis M, Kronenberg F, Meitinger T et al (2008) Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 4(11):e1000282
Griffin JL, Shockcor JP (2004) Metabolic profiles of cancer cells. Nat Rev Cancer 4(7):551–561
Guilbault C, Wojewodka G, Saeed Z, Hajduch M, Matouk E, De Sanctis JB et al (2009) Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide. Am J Respir Cell Mol Biol 41(1):100–106
Han J, Tschernutter V, Yang J, Eckle T, Borchers CH (2013) Analysis of selected sugars and sugar phosphates in mouse heart tissue by reductive amination and liquid chromatography-electrospray ionization mass spectrometry. Anal Chem 85(12):5965–5973
Han J, Lin K, Sequeira C, Borchers CH (2015) An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography-tandem mass spectrometry. Anal Chim Acta 854:86–94
Higashi N, Taniguchi M, Mita H, Osame M, Akiyama K (2002) A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma. Clin Exp Allergy 32(10):1484–1490
Hilvo M, Denkert C, Lehtinen L, Muller B, Brockmoller S, Seppanen-Laakso T et al (2011) Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res 71(9):3236–3245
Ho CS, Lam CW, Chan MH, Cheung RC, Law LK, Lit LC et al (2003) Electrospray ionisation mass spectrometry: principles and clinical applications. Clin Biochem Rev 24(1):3–12
Huang SK, Peters-Golden M (2008) Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time? Chest 133(6):1442–1450
Huda-Faujan N, Abdulamir AS, Fatimah AB, Anas OM, Shuhaimi M, Yazid AM et al (2010) The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J 4:53–58
Jain M, Nilsson R, Sharma S, Madhusudhan N, Kitami T, Souza AL et al (2012) Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336(6084):1040–1044
Jayasinghe NS, Dias DA (2013) A robust GC-MS method for the quantitation of fatty acids in biological systems. Methods Mol Biol 1055:39–56
Johnson CH, Ivanisevic J, Siuzdak G (2016) Metabolomics: beyond biomarkers and towards mechanisms. Nature Reviews 17(7):451–459
Karamanou M, Protogerou A, Tsoucalas G, Androutsos G, Poulakou-Rebelakou E (2016) Milestones in the history of diabetes mellitus: the main contributors. World J Diabetes 7(1):1–7
Katajamaa M, Oresic M (2007) Data processing for mass spectrometry-based metabolomics. J Chromatogr A 1158(1-2):318–328
Katajamaa M, Miettinen J, Oresic M (2006) MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics 22(5):634–636
Keyfi F, Varasteh A (2016) Development and validation of a GC-FID method for diagnosis of Methylmalonic Acidemia. Rep Biochem Mol Biol 4(2):104–109
Kim K, Aronov P, Zakharkin SO, Anderson D, Perroud B, Thompson IM et al (2009) Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics 8(3):558–570
Kim SJ, Kim N, Koh EH, Yoo HJ (2012) Identification of ethanolamine plasmalogens from complex lipid mixtures by MS/MS and Ag adduction. Anal Sci 28(12):1207–1212
Kim SJ, Back SH, Koh JM, Yoo HJ (2014) Quantitative determination of major platelet activating factors from human plasma. Anal Bioanal Chem 406(13):3111–3118
Kim S, Rhee JK, Yoo HJ, Lee HJ, Lee EJ, Lee JW et al (2015) Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer. Cancer Lett 357(2):488–497
Kim SH, Song HE, Kim SJ, Woo DC, Chang S, Choi WG et al (2017) Quantitative structural characterization of phosphatidylinositol phosphates from biological samples. J Lipid Res 58(2):469–478
Knittelfelder OL, Weberhofer BP, Eichmann TO, Kohlwein SD, Rechberger GN (2014) A versatile ultra-high performance LC-MS method for lipid profiling. J Chromatogr 951–952:119–128
Kvitvang HF, Andreassen T, Adam T, Villas-Boas SG, Bruheim P (2011) Highly sensitive GC/MS/MS method for quantitation of amino and nonamino organic acids. Anal Chem 83(7):2705–2711
Lanza IR, Zhang S, Ward LE, Karakelides H, Raftery D, Nair KS (2010) Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes. PLoS One 5(5):e10538
Larstad MA, Toren K, Bake B, Olin AC (2007) Determination of ethane, pentane and isoprene in exhaled air--effects of breath-holding, flow rate and purified air. Acta Physiol (Oxf) 189(1):87–98
Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. FASEB J 18(7):816–827
Lebovitz HE (1995) Diabetic ketoacidosis. Lancet 345(8952):767–772
Lei Z, Huhman DV, Sumner LW (2011) Mass spectrometry strategies in metabolomics. J Biol Chem 286(29):25435–25442
Levick SP, Loch DC, Taylor SM, Janicki JS (2007) Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J Immunol 178(2):641–646
Li C, Zheng S, You H, Liu X, Lin M, Yang L et al (2011) Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility. J Hepatol 54(6):1205–1213
Li L, Zhao J, Zhao Y, Lu X, Zhou Z, Zhao C et al (2016) Comprehensive investigation of tobacco leaves during natural early senescence via multi-platform metabolomics analyses. Sci Rep 6:37976
Liang X, Liu J, LeBlanc Y, Covey T, Ptak AC, Brenna JT et al (2007) Electron transfer dissociation of doubly sodiated glycerophosphocholine lipids. J Am Soc Mass Spectrom 18(10):1783–1788
Liberti MV, Locasale JW (2016) The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 41(3):211–218
Lim CK, Bilgin A, Lovejoy DB, Tan V, Bustamante S, Taylor BV et al (2017) Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression. Sci Rep 7:41473
Liu H, Yoo HJ, Hakansson K (2008) Characterization of phosphate-containing metabolites by calcium adduction and electron capture dissociation. J Am Soc Mass Spectrom 19(6):799–808
Lu W, Bennett BD, Rabinowitz JD (2008) Analytical strategies for LC-MS-based targeted metabolomics. J Chromatogr 871(2):236–242
Maeda S (1982) Pathology of experimental radiation pancarditis. II. Correlation between ultrastructural changes of the myocardial mitochondria and succinic dehydrogenase activity in rabbit heart receiving a single dose of X-ray irradiation. Acta Pathol Jpn 32(2):199–218
Mark TDD, Dunn GH (2013) Electron impact ionization. Springer, Cham
Matsuda F (2016) Technical challenges in mass spectrometry-based metabolomics. Mass Spectrom (Tokyo) 5(2):S0052
Metz TO, Zhang Q, Page JS, Shen Y, Callister SJ, Jacobs JM et al (2007) The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery. Biomark Med 1(1):159–185
Miekisch W, Schubert JK, Noeldge-Schomburg GF (2004) Diagnostic potential of breath analysis--focus on volatile organic compounds. Clin Chim Acta 347(1-2):25–39
Moustafa T, Fickert P, Magnes C, Guelly C, Thueringer A, Frank S et al (2012) Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury. Gastroenterology 142(1):140-51–140e12
Murray KK, Boyd RK, Eberlin MN, Langley GJ, Li L, Naito Y (2013) Definitions of terms relating to mass spectrometry (IUPACRecommendations 2013). Pure Appl Chem 85(5):1515–1609
Nardi-Agmon I, Peled N (2017) Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospects. Lung Cancer (Auckl) 8:31–38
Neary R, Watson CJ, Baugh JA (2015) Epigenetics and the overhealing wound: the role of DNA methylation in fibrosis. Fibrogenesis Tissue Repair 8:18
Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9(4):311–326
Nicholson JK, Lindon JC (2008) Systems biology: Metabonomics. Nature 455(7216):1054–1056
Ongay S, Hermans J, Bruins AP, Nieuwendijk AM, Overkleeft H, Bischoff R (2013) Electron transfer and collision induced dissociation of non-derivatized and derivatized desmosine and isodesmosine. J Am Soc Mass Spectrom 24(1):83–91
Osborn MP, Park Y, Parks MB, Burgess LG, Uppal K, Lee K et al (2013) Metabolome-wide association study of neovascular age-related macular degeneration. PLoS One 8(8):e72737
Papadimitropoulos MP, Vasilopoulou CG, Maga-Nteve C, Klapa MI (2018) Untargeted GC-MS metabolomics. Methods Mol Biol 1738:133–147
Paredi P, Kharitonov SA, Barnes PJ (2000a) Elevation of exhaled ethane concentration in asthma. Am J Respir Crit Care Med 162(4 Pt 1):1450–1454
Paredi P, Kharitonov SA, Leak D, Shah PL, Cramer D, Hodson ME et al (2000b) Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction. Am J Respir Crit Care Med 161(4 Pt 1):1247–1251
Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, Barnes PJ (2000c) Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162(2 Pt 1):369–373
Pavord ID, Ward R, Woltmann G, Wardlaw AJ, Sheller JR, Dworski R (1999) Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 160(6):1905–1909
Peled N, Hakim M, Bunn PA Jr, Miller YE, Kennedy TC, Mattei J et al (2012) Non-invasive breath analysis of pulmonary nodules. J Thorac Oncol 7(10):1528–1533
Perez ER, Knapp JA, Horn CK, Stillman SL, Evans JE, Arfsten DP (2016) Comparison of LC-MS-MS and GC-MS analysis of benzodiazepine compounds included in the drug demand reduction urinalysis program. J Anal Toxicol 40(3):201–207
Petras D, Jarmusch AK, Dorrestein PC (2017) From single cells to our planet-recent advances in using mass spectrometry for spatially resolved metabolomics. Curr Opin Chem Biol 36:24–31
Phillips M, Bauer TL, Cataneo RN, Lebauer C, Mundada M, Pass HI et al (2015) Blinded validation of breath biomarkers of lung Cancer, a potential ancillary to chest CT screening. PLoS One 10(12):e0142484
Pitt JJ, Eggington M, Kahler SG (2002) Comprehensive screening of urine samples for inborn errors of metabolism by electrospray tandem mass spectrometry. Clin Chem 48(11):1970–1980
Psathakis K, Mermigkis D, Papatheodorou G, Loukides S, Panagou P, Polychronopoulos V et al (2006) Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. Eur J Clin Investig 36(5):362–367
Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S et al (2011) The human serum metabolome. PLoS One 6(2):e16957
Qiu Y, Su M, Liu Y, Chen M, Gu J, Zhang J et al (2007) Application of ethyl chloroformate derivatization for gas chromatography-mass spectrometry based metabonomic profiling. Anal Chim Acta 583(2):277–283
Quehenberger O, Dennis EA (2011) The human plasma lipidome. N Engl J Med 365(19):1812–1823
Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH et al (2010) Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res 51(11):3299–3305
Ramautar R, Somsen GW, de Jong GJ (2009) CE-MS in metabolomics. Electrophoresis 30(1):276–291
Ramautar R, Somsen GW, de Jong GJ (2017) CE-MS for metabolomics: developments and applications in the period 2014-2016. Electrophoresis 38(1):190–202
Ren S, Shao Y, Zhao X, Hong CS, Wang F, Lu X et al (2016) Integration of metabolomics and Transcriptomics reveals major metabolic pathways and potential biomarker involved in prostate cancer. Mol Cell Proteomics 15(1):154–163
Richins RD, Rodriguez-Uribe L, Lowe K, Ferral R, O’Connell MA (2018) Accumulation of bioactive metabolites in cultivated medical cannabis. PLoS One 13(7):e0201119
Roberts LDS, L A, Gerszten RE, Clish CB (2012) Targeted metabolomics. Curr Protoc Mol Biol 98(1):30–32
Ross BM, Maxwell R, Glen I (2011) Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance. Prog Neuro-Psychopharmacol Biol Psychiatry 35(2):446–453
Sanak M, Gielicz A, Bochenek G, Kaszuba M, Nizankowska-Mogilnicka E, Szczeklik A (2011) Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype. J Allergy Clin Immunol 127(5):1141–7 e2
Sarbach C, Stevens P, Whiting J, Puget P, Humbert M, Cohen-Kaminsky S et al (2013) Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath. Ann Pharm Fr 71(4):203–215
Sas KM, Karnovsky A, Michailidis G, Pennathur S (2015) Metabolomics and diabetes: analytical and computational approaches. Diabetes 64(3):718–732
Shehada N, Cancilla JC, Torrecilla JS, Pariente ES, Bronstrup G, Christiansen S et al (2016) Silicon nanowire sensors enable diagnosis of patients via exhaled breath. ACS Nano 10(7):7047–7057
Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G (2006) XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78(3):779–787
Smith R, Ventura D, Prince JT (2015) LC-MS alignment in theory and practice: a comprehensive algorithmic review. Brief Bioinform 16(1):104–117
Smkmrmstt M (2012) Bioinformatics tools for mass spectroscopy-based Metabolomic data processing and analysis. Curr Bioinforma 7(1):96–108
Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J et al (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231):910–914
Strassburg K, Huijbrechts AM, Kortekaas KA, Lindeman JH, Pedersen TL, Dane A et al (2012) Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery. Anal Bioanal Chem 404(5):1413–1426
Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wagele B et al (2011a) Human metabolic individuality in biomedical and pharmaceutical research. Nature 477(7362):54–60
Suhre K, Wallaschofski H, Raffler J, Friedrich N, Haring R, Michael K et al (2011b) A genome-wide association study of metabolic traits in human urine. Nat Genet 43(6):565–569
Sun C, Li T, Song X, Huang L, Zang Q, Xu J et al (2019) Spatially resolved metabolomics to discover tumor-associated metabolic alterations. Proc Natl Acad Sci U S A 116(1):52–57
Takats Z, Wiseman JM, Gologan B, Cooks RG (2004) Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science 306(5695):471–473
Tao X, Liu Y, Wang Y, Qiu Y, Lin J, Zhao A et al (2008) GC-MS with ethyl chloroformate derivatization for comprehensive analysis of metabolites in serum and its application to human uremia. Anal Bioanal Chem 391(8):2881–2889
Teichgraber V, Ulrich M, Endlich N, Riethmuller J, Wilker B, De Oliveira-Munding CC et al (2008) Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 14(4):382–391
Theodoridis H, Wilson I (2008) LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics. TrAC Trends Anal Chem 27:251–260
Theodoridis GA, Gika HG, Want EJ, Wilson ID (2012) Liquid chromatography-mass spectrometry based global metabolite profiling: a review. Anal Chim Acta 711:7–16
Tsai TH, Tadesse MG, Wang Y, Ressom HW (2013a) Profile-based LC-MS data alignment--a Bayesian approach. IEEE/ACM Trans Comput Biol Bioinform 10(2):494–503
Tsai TH, Tadesse MG, Di Poto C, Pannell LK, Mechref Y, Wang Y et al (2013b) Multi-profile Bayesian alignment model for LC-MS data analysis with integration of internal standards. Bioinformatics 29(21):2774–2780
Vahamaa H, Koskinen VR, Hosia W, Moulder R, Nevalainen OS, Lahesmaa R et al (2011) PolyAlign: a versatile LC-MS data alignment tool for landmark-selected and -automated use. Int J Proteomics 2011:450290
van Laarhoven A, Dian S, Aguirre-Gamboa R, Avila-Pacheco J, Ricano-Ponce I, Ruesen C et al (2018) Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study. Lancet Infect Dis 18(5):526–535
Vandenbogaert M, Li-Thiao-Te S, Kaltenbach HM, Zhang R, Aittokallio T, Schwikowski B (2008) Alignment of LC-MS images, with applications to biomarker discovery and protein identification. Proteomics 8(4):650–672
Vander Heiden MG (2011) Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov 10(9):671–684
Vaniya A, Fiehn O (2015) Using fragmentation trees and mass spectral trees for identifying unknown compounds in metabolomics. Trends Analyt Chem 69:52–61
Vasilopoulou CG, Margarity M, Klapa MI (2016) Metabolomic analysis in brain research: opportunities and challenges. Front Physiol 7:183
Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M et al (2018) Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-National Cohort Study. Gastroenterology 155(2):443–457
Villas-Boas SG, Mas S, Akesson M, Smedsgaard J, Nielsen J (2005) Mass spectrometry in metabolome analysis. Mass Spectrom Rev 24(5):613–646
Villoslada P, Alonso C, Agirrezabal I, Kotelnikova E, Zubizarreta I, Pulido-Valdeolivas I et al (2017) Metabolomic signatures associated with disease severity in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 4(2):e321
Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10(3):181–193
Wang Z, Wang C (2013) Is breath acetone a biomarker of diabetes? A historical review on breath acetone measurements. J Breath Res 7(3):037109
Wang C, Kong H, Guan Y, Yang J, Gu J, Yang S et al (2005) Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anal Chem 77(13):4108–4116
Wang Y, Chen X, Li Q, Zhong D (2008) Metabolite identification of arbidol in human urine by the study of CID fragmentation pathways using HPLC coupled with ion trap mass spectrometry. J Mass Spectrom 43(8):1099–1109
Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17(4):448–453
Want EJ, Cravatt BF, Siuzdak G (2005) The expanding role of mass spectrometry in metabolite profiling and characterization. Chembiochem 6(11):1941–1951
Want EJ, Wilson ID, Gika H, Theodoridis G, Plumb RS, Shockcor J et al (2010) Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc 5(6):1005–1018
Want EJ, Masson P, Michopoulos F, Wilson ID, Theodoridis G, Plumb RS et al (2013) Global metabolic profiling of animal and human tissues via UPLC-MS. Nat Protoc 8(1):17–32
Warburg O (1956) On the origin of cancer cells. Science 123(3191):309–314
Watrous JD, Henglin M, Claggett B, Lehmann KA, Larson MG, Cheng S et al (2017) Visualization, quantification, and alignment of spectral drift in population scale untargeted metabolomics data. Anal Chem 89(3):1399–1404
Wenzel SE, Busse WW, National Heart L (2007) Blood Institute's severe asthma research P. severe asthma: lessons from the severe asthma research program. J Allergy Clin Immunol 119(1):14–21
Worley BP (2013) R. Multivariate analysis in metabolomics. Curr Metabolomics 1(1):92–107
Wu AHB (2006) Clinical guide to laboratory tests, 4th edn. Saunders/Elsevier, St. Louis, MO
Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214(2):199–210
Xia J, Wishart DS (2011) Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc 6(6):743–760
Xiao JF, Zhou B, Ressom HW (2012) Metabolite identification and quantitation in LC-MS/MS-based metabolomics. Trends Analyt Chem. 32:1–14
Yamashita MF, John B (1984) Electrospray ion source. Another variation on the free-jet theme. J Phys Chem 88(20):4451–4459
Yang J, Schmelzer K, Georgi K, Hammock BD (2009) Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry. Anal Chem 81(19):8085–8093
Yang J, Dong H, Hammock BD (2011) Profiling the regulatory lipids: another systemic way to unveil the biological mystery. Curr Opin Lipidol 22(3):197–203
Yoo HJ, Hakansson K (2011) Determination of phospholipid regiochemistry by Ag(I) adduction and tandem mass spectrometry. Anal Chem 83(4):1275–1283
Yoo HJ, Liu H, Hakansson K (2007) Infrared multiphoton dissociation and Electron-induced dissociation as alternative MS/MS strategies for metabolite identification. Anal Chem 20:7858–7866
Yoo HJ, Wang N, Zhuang S, Song H, Hakansson K (2011) Negative-ion electron capture dissociation: radical-driven fragmentation of charge-increased gaseous peptide anions. J Am Chem Soc 133(42):16790–16793
Yuan M, Breitkopf SB, Yang X, Asara JM (2012) A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc 7(5):872–881
Yugi K, Kuroda S (2018) Metabolism as a signal generator across trans-omic networks at distinct time scales. Curr Opin Syst Biol 8:59–66
Zeng M, Cao H (2018) Fast quantification of short chain fatty acids and ketone bodies by liquid chromatography-tandem mass spectrometry after facile derivatization coupled with liquid-liquid extraction. J Chromatogr 1083:137–145
Zhang W, Hankemeier T, Ramautar R (2017) Next-generation capillary electrophoresis-mass spectrometry approaches in metabolomics. Curr Opin Biotechnol 43:1–7
Zhao X, Fritsche J, Wang J, Chen J, Rittig K, Schmitt-Kopplin P et al (2010) Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics 6(3):362–374
Zheng X, Qiu Y, Zhong W, Baxter S, Su M, Li Q et al (2013) A targeted metabolomic protocol for short-chain fatty acids and branched-chain amino acids. Metabolomics 9(4):818–827
Zhou B, Xiao JF, Tuli L, Ressom HW (2012) LC-MS-based metabolomics. Mol BioSyst 8(2):470–481
Acknowledgments
This study was supported by a grant (2018IL0540, 2019IL0540) from the Asan Institute of Life Sciences, Asan Medical Center, Seoul and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2019R1F1A1056286).
Conflicts of Interest
The authors declare no competing interests relevant to this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kim, S.J., Song, H.E., Lee, H.Y., Yoo, H.J. (2021). Mass Spectrometry-based Metabolomics in Translational Research. In: Kim, J.K., Kim, J.K., Pack, CG. (eds) Advanced Imaging and Bio Techniques for Convergence Science. Advances in Experimental Medicine and Biology, vol 1310. Springer, Singapore. https://doi.org/10.1007/978-981-33-6064-8_19
Download citation
DOI: https://doi.org/10.1007/978-981-33-6064-8_19
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-6063-1
Online ISBN: 978-981-33-6064-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)